Conferences

Dr Alex Asiimwe, EFPIA lead for PIONEER, discusses the unique public-private aspects of BD4BO ( Dr Alex Asiimwe - Director, BAYER AG, Medical affairs, Epidemiology )

Prof Anders Bjartell discusses the data sources and access of the PIONEER data models ( Prof Anders Bjartell - Skåne University Hospital, Malmö, Lund University, Sweden )

Dr Billy Franks explains the importance of data analysis plans for PIONEER’s research questions ( Dr Billy Franks - Astellas Pharma B.V. )

Denis Horgan explains the importance of actively engaging policy makers in PIONEER ( Denis Horgan - Executive Director, European Alliance for Personalised Medicine )

Prof James N’Dow, Academic lead for PIONEER, reflects on the first twelve months of the project ( Prof James N’Dow - Chairperson, European Association of Urology Guidelines Office )

Louise Fullwood explains the legal and ethical issues around data privacy within PIONEER ( Louise Fullwood - Legal Director, Pinsent Masons )

Prof Maria Ribal discusses how effective dissemination is key to PIONEER’s long-term success ( Prof Maria Ribal - Chairperson, EAU Guidelines Dissemination Committee )

Dr Mieke Van Hemelrijck explains the importance of define core outcome sets for prostate cancer ( Dr Mieke Van Hemelrijck - Kings College London, Translational Oncology &amp; Urology Research (TOUR) )

Dr Thomas Abbott, EFPIA co-lead for PIONEER, discusses data sources and access to data ( Dr Thomas Abbott - Head, Real World Evidence at Astellas Pharmaceuticals )

Dr Zsuzsanna Devecseri, EFPIA co-lead for PIONEER, discusses prostate cancer outcomes ( Dr Zsuzsanna Devecseri - Head, Global Oncology Medical, Sanofi )